John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIO
2326
DELISTED
City Office REIT
CIO
| $469K | ﹤0.01% |
+90,084
| New | +$454K |
|
2327
LivePerson
LPSN
$34.2M
| $468K | ﹤0.01% |
31,290
-62,711
| -67% | -$2.16M |
|
2328
Cathay General Bancorp
CATY
$4.13B
| $468K | ﹤0.01% |
12,367
+5,167
| +72% | +$209K |
|
2329
Sierra Bancorp
BSRR
$512M
| $466K | ﹤0.01% |
23,090
+7,629
| +49% | +$150K |
|
2330
Silvercrest Asset Management
SAMG
$78.5M
| $465K | ﹤0.01% |
29,406
-2,500
| -8% | -$41K |
|
2331
Euroseas
ESEA
$543M
| $462K | ﹤0.01% |
15,848
-3,721
| -19% | -$112K |
|
2332
Genworth Financial
GNW
$3.73B
| $462K | ﹤0.01% |
71,862
-99,727
| -58% | -$624K |
|
2333
Hooker Furnishings Corp
HOFT
$148M
| $462K | ﹤0.01% |
19,237
+2,162
| +13% | +$51.8K |
|
2334
Arcosa
ACA
$7.13B
| $461K | ﹤0.01% |
5,372
-7,710
| -59% | -$628K |
|
2335
PubMatic
PUBM
$754M
| $461K | ﹤0.01% |
+19,427
| New | +$348K |
|
2336
Worthington Enterprises
WOR
$2.8B
| $461K | ﹤0.01% |
7,400
-1,600
| -18% | -$95.3K |
|
2337
Farmers National Banc Corp
FMNB
$925M
| $460K | ﹤0.01% |
34,430
+5,778
| +20% | +$78.1K |
|
2338
Arteris
AIP
$1.14B
| $458K | ﹤0.01% |
62,574
+43,674
| +231% | +$281K |
|
2339
Zumiez
ZUMZ
$311M
| $457K | ﹤0.01% |
+30,068
| New | +$513K |
|
2340
Mercantile Bank Corp
MBWM
$1.04B
| $456K | ﹤0.01% |
11,840
-2,892
| -20% | -$110K |
|
2341
Avantis US Small Cap Equity ETF
AVSC
$3.18B
| $456K | ﹤0.01% |
+8,700
| New | +$435K |
|
2342
Lexicon Pharmaceuticals
LXRX
$1.04B
| $455K | ﹤0.01% |
189,431
-13,456
| -7% | -$28.9K |
|
2343
Lantronix
LTRX
$261M
| $454K | ﹤0.01% |
127,525
+28,265
| +28% | +$139K |
|
2344
Waterstone Financial
WSBF
$378M
| $453K | ﹤0.01% |
37,256
-1,379
| -4% | -$17.5K |
|
2345
Renaissance IPO ETF
IPO
$152M
| $453K | ﹤0.01% |
10,900
-15,800
| -59% | -$593K |
|
2346
WEX
WEX
$6.81B
| $451K | ﹤0.01% |
1,900
-7,100
| -79% | -$1.53M |
|
|
API
2347
Agora
API
$348M
| $446K | ﹤0.01% |
177,655
-528
| -0.3% | -$1.42K |
|
|
BASE
2348
DELISTED
Couchbase
BASE
| $445K | ﹤0.01% |
16,900
+7,638
| +82% | +$199K |
|
|
ACCD
2349
DELISTED
Accolade Inc
ACCD
| $443K | ﹤0.01% |
42,279
+15,942
| +61% | +$181K |
|
2350
iShares US Consumer Discretionary ETF
IYC
$1.22B
| $443K | ﹤0.01% |
5,400
-500
| -8% | -$39K |
|
Similar funds
John Overdeck's Q1 2024 Portfolio in Review
As of Q1 2024, John Overdeck held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
John Overdeck withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, John Overdeck opened a new position in Pfizer worth $234M.
- John Overdeck's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- John Overdeck added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- John Overdeck's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- John Overdeck fully exited Rivian in Q1 2024, selling an estimated $158M.
- John Overdeck's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- John Overdeck opened 408 new positions and closed 532 in Q1 2024.
- John Overdeck's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.